X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Fischer Medical Ventures Ltd.
BSE CODE: 524743   |   NSE CODE: NA   |   ISIN CODE : INE771F01025   |   30-Apr-2025 Hrs IST
BSE NSE
Rs. 848.65
35.9 ( 4.42% )
 
Prev Close ( Rs.)
812.75
Open ( Rs.)
800.10
 
High ( Rs.)
870.00
Low ( Rs.)
786.50
 
Volume
8998
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
24-Mar-2025 26-Mar-2025 Inter alia, to consider the following:- 1. Noting the Resignation of Ms. Jeena Dineshchandra Suthar (DIN: 09852258) as Independent Director of the Company with effect from closing hours of 26 th March 2025. 2. Consider and Approve on the recommendation of Nomination and Remuneration Committee the Appointment of Ms. Jaya Ankur Singhania (DIN: 01990322) as Independent Director of the Company with effect from 26 th March 2025. 3. Consider and Approve the Notice of Postal Ballot with explanatory statements and other related matters. 4. Other General Business and ancillary matters.
07-Feb-2025 14-Feb-2025 Quarterly Results
30-Dec-2024 03-Jan-2025 Inter alia, to consider and approve:- 1. The withdrawal of the proposed preferential issue which was announced by the Company on December 26, 2024; 2. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.; 3. The day, date, time and venue for Extra-Ordinary General Meeting of the Company; 4. The notice for Extra-Ordinary General Meeting (EOGM) of the Company; 5. To fix the date for book closure (Register of Member); 6. To appoint Mr. Nuren Lodaya Practicing Company Secretary (Membership No. 60128), proprietor of M/s. Nuren Lodaya & Associates. as Scrutinizer for conducting e-voting and poll process for General Meeting of the Company; 7. To transact other incidental and ancillary matters as may be decided by the Board with the permission of Chairperson.
05-Nov-2024 13-Nov-2024 Quarterly Results
09-Aug-2024 14-Aug-2024 Preferential Issue of shares & Quarterly Results
22-May-2024 30-May-2024 Audited Results
30-Apr-2024 04-May-2024 Inter alia, to consider and approve:- 1. The Change in management of the Company subsequent to completion of open offer in accordance with the provisions of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011; 2. The setting up of corporate office Address of the Company in Chennai, Tamil Nadu; and 3. To transact other incidental and ancillary matters as may be decided by the board
05-Feb-2024 12-Feb-2024 Quarterly Results
12-Dec-2023 15-Dec-2023 Inter alia, to consider and approve: 1. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.; 2. To transact other incidental and ancillary matters as may be decided by the board.
25-Oct-2023 01-Nov-2023 Quarterly Results
Page 1 of 9
PREV || NEXT